ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2804

Radiological Outcome Of Joints With MRI Detected Subclinical Inflammation In Early Arthritis Patients

A. Krabben1, W. Stomp2, J. a. B. van Nies1, T.W.J. Huizinga1, D. van der Heijde3, J.L Bloem2, M. Reijnierse2 and A. H. M. van der Helm-van Mil1, 1Rheumatology, Leiden University Medical Center, Leiden, Netherlands, 2Radiology, Leiden University Medical Center, Leiden, Netherlands, 3Department of Rheumatology, Leiden University Medical Center, Leiden, Netherlands

Meeting: 2013 ACR/ARHP Annual Meeting

Keywords: Inflammation, magnetic resonance imaging (MRI) and radiography

  • Tweet
  • Email
  • Print
Session Information

Title: Imaging in Rheumatoid Arthritis

Session Type: Abstract Submissions (ACR)

Background/Purpose:  Extremity-MRI is becoming important in Rheumatoid Arthritis (RA) research as it is a sensitive tool to assess inflammation. Inflammation is measured by three features: bone marrow edema (inflammation of bone), synovitis and tenosynovitis. Part of the inflammatory lesions detected by MRI are subclinical, indicating that these were not observed by physical examination. The relevance of subclinical inflammation detected by MRI in a population of early arthritis patients for to the disease course is not known. In this study we investigated the relevance of subclinical inflammation on MRI in early arthritis patients for  radiological joint damage.

Methods:  179 early arthritis patients (median symptom duration of 15 weeks) included in the Leiden Early Arthritis Clinic underwent a 68-tender and 66-swollen joint count (including MCP, wrist and MTP joints) and a 1.5T MRI of the MCP (2-4), wrist and MTP (1-5) joints at the most painful side at baseline. Synovitis and bone marrow edema were scored according to the RAMRIS method; tenosynovitis at the wrists and MCP joints was also determined. Scoring was performed by two readers and the average scores were studied. Radiographs of hands and feet were made at baseline and after one year of follow-up and scored according to the Sharp-van-der-Heijde scoring method (SHS).

Results:  1,790 small joints of 179 patients were studied. Of these joints 1,525 (85%) were not swollen at physical examination. Of all clinically non-swollen joints, any subclinical inflammation was present on MRI in 25%; 15% had bone marrow edema, 15% synovitis and 18% tenosynovitis. When evaluating these clinically non-swollen joints in relation to the radiographs at year-1, 7% of the joints had SHS ≥1 and 2% SHS progression ≥1.

The subclinical inflamed joints were evaluated with progression of radiological joint damage over the first year (SHS progression ≥1) as outcome. When comparing the non-swollen joints with and without any inflammation on MRI, 4% versus 1% had SHS progression ≥1, (RR 3.5 (1.3-9.6)). For bone marrow edema this was 6.5% versus 1% (RR 5.3 (2.0-14.0), for synovitis this was 5% versus 1% (RR 3.4 (1.2-9.3)) and for tenosynovitis this was 4% versus 1% (RR 3.0 (0.7-12.7)). Hence, although radiological progression was infrequent, it was significantly increased in joints with subclinical synovitis or bone marrow edema. For comparison we studied the outcome of the swollen joints. 8% of all swollen joints had SHS progression ≥1 over the first year, indicating that the frequency of progression in subclinical inflamed joints almost equaled the frequency of progression in clinically swollen joints.

Conclusion:  Joints with subclinical inflammation detected by MRI have an increased risk of progression in structural damage in early arthritis. This points to the relevance of subclinical inflammation for the disease outcome in RA.


Disclosure:

A. Krabben,
None;

W. Stomp,
None;

J. A. B. van Nies,
None;

T. W. J. Huizinga,
None;

D. van der Heijde,
None;

J. L. Bloem,
None;

M. Reijnierse,
None;

A. H. M. van der Helm-van Mil,
None.

  • Tweet
  • Email
  • Print

« Back to 2013 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/radiological-outcome-of-joints-with-mri-detected-subclinical-inflammation-in-early-arthritis-patients/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology